Association of oral endothelin receptor antagonists with risks of cardiovascular events and mortality: meta-analysis of randomized controlled trials

被引：0
|
作者：
Yu Pan
Chun Hu
Pei Hua Chen
Yan Hong Gu
Qing Yan Qiao
Li Hua Pan
Dong Chi Zhou
Hui Fang Gu
Shun Kun Fu
Hui Min Jin
机构：
[1] Shanghai Jiaotong University,Division of Nephrology, Shanghai Ninth People’s Hospital, School of Medicine
[2] Fudan University,Division of Nephrology, Shanghai Pudong Hospital
[3] Pudong Medical Center,undefined
来源：
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词：
Oral endothelin receptor antagonist; Cardiovascular events; All-cause mortality; Major adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：267 / 278
页数：11
相关论文
共 50 条
  • [21] Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: A systematic review and meta-analysis of randomized controlled trials
    Elbers, Laura P. B.
    Sjouke, Barbara
    Zannad, Faiez
    Cicoira, Mariantonietta
    Vizzardi, Enrico
    Vaclavik, Jan
    Gerdes, Victor E. A.
    Squizzato, Alessandro
    THROMBOSIS RESEARCH, 2016, 144 : 32 - 39
  • [22] Hepatotoxicity in patients treated with endothelin receptor antagonists: Systematic review and meta-analysis of randomized clinical trials
    Macias St-Gerons, Diego
    de la Fuente Honrubia, Cesar
    Montero Corominas, Dolores
    Catala-Lopez, Ferran
    MEDICINA CLINICA, 2014, 142 (08): : 333 - 342
  • [23] Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials
    Monami, Matteo
    Zannoni, Stefania
    Pala, Laura
    Silverii, Antonio
    Andreozzi, Francesco
    Sesti, Giorgio
    Mannucci, Edoardo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 240 : 414 - 421
  • [24] Erratum to: Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials
    Matteo Monami
    Ilaria Dicembrini
    Edoardo Mannucci
    Acta Diabetologica, 2017, 54 : 37 - 38
  • [25] Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials
    Mannucci, Edoardo
    Monami, Matteo
    Candido, Riccardo
    Pintaudi, Basilio
    Targher, Giovanni
    Delle Monache, Lina
    Gallo, Marco
    Giaccari, Andrea
    Masini, Maria Luisa
    Mazzone, Fulvia
    Medea, Gerardo
    Trento, Marina
    Turchetti, Giuseppe
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (10) : 1601 - 1608
  • [26] Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta-analysis of randomized controlled trials
    Zhou, Y.
    Chi, J.
    Huang, Y.
    Dong, B.
    Lv, W.
    Wang, Y. G.
    DIABETIC MEDICINE, 2021, 38 (01)
  • [27] ASSOCIATION BETWEEN APOLIPOPROTEIN B AND CARDIOVASCULAR RISK: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Galimberti, F.
    Catapano, A. L.
    Cupido, A. J.
    Katzmann, J. L.
    Ference, B. A.
    ATHEROSCLEROSIS, 2020, 315 : E5 - E5
  • [28] Assessing the risk of angiotensin receptor blockers on major cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
    Wanas, Yara
    Bashir, Rim
    Islam, Nazmul
    Furuya-Kanamori, Luis
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [29] NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials
    Kishi, Taro
    Iwata, Nakao
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (09) : 1143 - 1149
  • [30] Angiotensin Receptor-Neprilysin Inhibitor Effects on Atherosclerotic Cardiovascular Disease Events: A Meta-Analysis of Randomized Controlled Trials
    Ravani, Lis Victoria
    Gewehr, Douglas Mesadri
    Calomeni, Pedro
    Gauza, Mateus de Miranda
    Pereira, Jussara
    Cardoso, Rhanderson
    Ribeiro, Henrique Barbosa
    Bocchi, Edimar
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 205 : 259 - 268
12345